Stay updated on UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Sign up to get notified when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.

Latest updates to the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page
- Check4 days agoChange DetectedAn updated 'Last Update Posted' timestamp and minor layout adjustments are present. Core study details, eligibility criteria, and outcomes remain unchanged.SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check33 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference4%

- Check40 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

- Check54 days agoChange DetectedUpdated version to v3.0.2 and removed the Back to Top link; no substantive changes to core content or data.SummaryDifference0.3%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

- Check68 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several specific terms related to diseases and location details have been removed.SummaryDifference3%

Stay in the know with updates to UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.